Fund Holdings — Pennant Investors, LP

Total Portfolio Value:
$335.97M
Total Bought:
$61.32M
Total Sold:
$97.24M
Net Transaction:
-$35.92M
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
EchoStar CorporationCL A(ECHO)2,153,2092,320,837+167,628$38.35M$57.60M17.15%+$19.25M
Perimeter Solutions, Inc.(PRM)2,300,0002,700,000+400,000$18.01M$36.31M10.81%+$18.31M
Micron Technology, Inc.(MU)431,000340,432-90,568$56.69M$35.31M10.51%-$21.38M
Amazon.com, Inc.(AMZN)240,000182,000-58,000$46.38M$33.91M10.09%-$12.47M
Antero Resources Corporation(AR)836,0001,126,000+290,000$27.28M$32.26M9.60%+$4.98M
TransDigm Group Incorporated(TDG)32,37119,371-13,000$41.36M$27.64M8.23%-$13.71M
Alphabet Inc.CL A(GOOG)183,000153,000-30,000$33.33M$25.38M7.55%-$7.96M
Microsoft Corporation(MSFT)80,00051,000-29,000$35.76M$21.95M6.53%-$13.81M
Vertiv Holdings CoCL A(VRT)115,000160,000+45,000$9.96M$15.92M4.74%+$5.96M
GE Vernova Inc.(GEV)60,00060,0000$10.29M$15.30M4.55%+$5.01M
Valmont Industries, Inc.(VMI)40,00040,0000$10.98M$11.60M3.45%+$620.0K
Core Scientific, Inc.(CORZ)500,000794,813+294,813$4.65M$9.43M2.81%+$4.78M
Iris Energy Ltd
ORDINARY SHARES
470,000940,000+470,000$5.31M$7.93M2.36%+$2.63M
Asml Holding N VN Y REGISTRY SHS
N Y REGISTRY SHS
06,500+6,500$0$5.42M1.61%+$5.42M
Grab Holdings LimitedW EXP 99 99 999
*W EXP 99/99/999
80,00080,0000$12.9K$19.1K0.01%+$6.2K
89bio Inc44,5000-44,500$356.4K$0—-$356.4K
Agios Pharmaceuticals, Inc.(AGIO)15,1000-15,100$651.1K$0—-$651.1K
Allakos Inc186,1000-186,100$186.1K$0—-$186.1K
Allogene Therapeutics Inc128,4000-128,400$299.2K$0—-$299.2K
Allovir Inc215,7000-215,700$156.0K$0—-$156.0K
Altimmune, Inc.(ALT)109,8000-109,800$730.2K$0—-$730.2K
Arcturus Therapeutics Holdings Inc.(ARCT)13,1000-13,100$319.0K$0—-$319.0K
Arcus Biosciences, Inc.(RCUS)23,7000-23,700$361.0K$0—-$361.0K
Arcutis Biotherapeutics, Inc.(ARQT)170,9000-170,900$1.59M$0—-$1.59M
BioXcel Therapeutics, Inc.(BTAIQ)83,9000-83,900$107.4K$0—-$107.4K
Bluebird Bio Inc87,4000-87,400$86.0K$0—-$86.0K
Coherus Oncology, Inc.(CHRS)168,1000-168,100$290.8K$0—-$290.8K
Compass Therapeutics, Inc.(CMPX)199,0000-199,000$199.0K$0—-$199.0K
Enanta Pharmaceuticals, Inc.(ENTA)35,1000-35,100$455.2K$0—-$455.2K
Erasca, Inc.(ERAS)166,2000-166,200$392.2K$0—-$392.2K
Fate Therapeutics, Inc.(FATE)146,1000-146,100$479.2K$0—-$479.2K
Fibrogen Inc768,4000-768,400$685.6K$0—-$685.6K
Getaround Inc1,348,1530-1,348,153$188.7K$0—-$188.7K
Igm Biosciences Inc64,9000-64,900$445.9K$0—-$445.9K
MacroGenics, Inc.(MGNX)43,8000-43,800$186.2K$0—-$186.2K
Novavax, Inc.(NVAX)60,3000-60,300$763.4K$0—-$763.4K
Nurix Therapeutics, Inc.(NRIX)56,8000-56,800$1.19M$0—-$1.19M
Relay Therapeutics, Inc.(RLAY)42,4000-42,400$276.4K$0—-$276.4K
Replimune Group, Inc.(REPL)30,5000-30,500$274.5K$0—-$274.5K
Sage Therapeutics Inc17,5000-17,500$190.1K$0—-$190.1K
Seres Therapeutics, Inc.(MCRB)292,3000-292,300$211.6K$0—-$211.6K
The Odp Corp400,0000-400,000$15.71M$0—-$15.71M
Travere Therapeutics, Inc.(TVTX)55,8000-55,800$458.7K$0—-$458.7K
uniQure N.V.SHS(QURE)48,5000-48,500$217.3K$0—-$217.3K
Zentalis Pharmaceuticals, Inc.(ZNTL)32,4000-32,400$132.5K$0—-$132.5K
Zymeworks Inc.(ZYME)38,7000-38,700$329.3K$0—-$329.3K
Page 1 of 1
Pennant Investors, LP — 13F Holdings — Q3 2024 | TickerTrail